Sign Up to like & get
recommendations!
0
Published in 2018 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2018.09.007
Abstract: Elderly patients with schizophrenia are a particularly vulnerable group often excluded from clinical trials. Currently there is no evidence-synthesis about the efficacy and safety of antipsychotics in this subgroup. We reviewed all randomized-controlled-trials, about antipsychotics…
read more here.
Keywords:
drugs elderly;
patients schizophrenia;
elderly patients;
meta ... See more keywords